Why did Seelos Therapeutics Inc. (SEEL) stock price plunge in premarket?
Seelos Therapeutics, Inc. (SEEL), a clinical-stage biopharmaceutical company specializing to develop technologies and therapeutics for the treatment of central nervous system and respiratory disorders, declared the commencement of an underwritten public offering of shares of common stock. At last check, shares of Seelos Therapeutics Inc. (SEEL) were down -7.34% at $3.03. SEEL’s stock closed the […]
Seelos Therapeutics Inc. (SEEL) stock gains during pre-market trading. Why is it so?
Seelos Therapeutics Inc. (NASDAQ: SEEL) stock declined by 24.28% at the last close whereas the SEEL stock price surge by 4.07% in the pre-market trading session. Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical corporation dedicated to the discovery and production of new therapeutics to meet the unmet medical needs of patients suffering from CNS conditions […]
